METHOD OF INDUCING AN EARLY RESPONSE OF T-CELLS IN MEMORY OF ANTI-TUMOR VACCINE FROM SHORT PEPTIDES

摘要

The present invention relates to T-specific immunotherapy with therapeutic peptides for use in the treatment of cancer in HLA-A2 (human leukocyte antigen A2) -positive patient, where said treatment includes a priming period consisting of two to three uses of said T-specific immunotherapy with therapeutic peptides, through this, inducing a central T-cell memory response.